TL;DR
MedPage Today published a weekly roundup of comments from clinicians and health officials on AI in medicine, GLP-1 medications, tick larvae, cancer treatment and eye health. The remarks include Health Secretary Robert F. Kennedy Jr.’s assertion that AI could offer a better-informed second opinion than any U.S. doctor; the roundup does not provide evidence evaluating that claim.
MedPage Today published its October 4, 2026, weekly roundup of comments heard by its reporters, bringing together remarks on artificial intelligence in health care, GLP-1 drugs, tick exposure, cancer treatment and eye conditions. The collection includes Health Secretary Robert F. Kennedy Jr.’s claim that AI could provide a second opinion better informed than any doctor in the country, but the roundup does not offer evidence comparing AI systems with physicians.
Kennedy’s comment was presented as suggesting that patients should have more confidence in artificial intelligence than U.S. physicians. The brief item does not specify which AI tool he meant, what kinds of medical decisions he was discussing or what evidence supported the comparison. It records the remark rather than testing its accuracy.
Other comments addressed possible applications and limits of AI. Stephanie Carlton of the Centers for Medicare & Medicaid Services called preventive care during Medicare annual wellness visits a significant opportunity for AI. By contrast, researcher Gideon Meyerowitz-Katz criticized an AI-powered “Research Boot Camp” that promises a journal-ready manuscript in one weekend, comparing the guarantee to promising participants a chance to apply for a television obstacle-course competition after a two-day fitness camp.
The roundup also included Bianca Maria Piraccini’s comment on research linking GLP-1 medication use with a higher likelihood of onycholysis, or nail detachment. Piraccini, of the University of Bologna, said the association was unusual because nail detachment cannot be related to weight loss. The summary provides no study details or evidence establishing a cause-and-effect relationship.
AI Claims and Clinical Judgment
The roundup puts sharply different views of AI’s role in health care side by side: Kennedy described it as potentially superior to doctors for a second opinion, while Carlton pointed to a specific possible use in preventive care. Those are reported statements, not findings from a comparative trial. The distinction matters to patients weighing how to use AI-generated health information and to clinicians and policymakers considering its place in care.
The remaining comments also show how a short weekly roundup can flag emerging research and clinical issues without resolving them. A reported association between a medication and a symptom is not, by itself, proof that the medication caused it. Likewise, remarks about older cancer patients, severe nearsightedness and uncommon complications from familiar infections point to topics that require individual clinical assessment, rather than universal conclusions.
AI-powered medical second opinion tools
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
Eight Remarks Across Medicine
MedPage Today described the item as a collection of quotable comments heard by its reporters, not as a single study or policy announcement. The report was published October 4, 2026, and labeled a two-minute read. Its entries name speakers and briefly identify the subjects behind their remarks, but do not provide full transcripts, links to underlying research or detailed accounts of the events where the comments were made.
Beyond AI and GLP-1 medications, the roundup covered lone star tick larvae, which University of Minnesota researcher Jonathan Oliver warned can swarm and bite; treatment considerations for older or frail people with diffuse large B-cell lymphoma, discussed by Pallawi Torka of Memorial Sloan Kettering Cancer Center; and concerns that severe myopia can be associated with cataracts, glaucoma and other eye problems, raised by Rupa Wong of the Honolulu Eye Clinic.
Two further comments dealt with unusual disease presentations. Norman Saffra of Albert Einstein College of Medicine said uncommon presentations of common illnesses were more familiar in his experience than common presentations of rare illnesses. His remark referred to a case in which a routine strep infection in an adult triggered a rare eye condition. The roundup offers this as a clinical observation, not a measure of how often such cases occur.
“It can give you a second opinion that is much better informed than any doctor in the country.”
— Robert F. Kennedy Jr., U.S. health secretary
As an affiliate, we earn on qualifying purchases.
Evidence Behind the Remarks
The roundup does not identify the AI system behind Kennedy’s comparison or provide supporting data, clinical examples or qualifications to his statement. It also does not establish that AI can outperform physicians when providing second opinions. The claim remains Kennedy’s characterization in the material provided.
For the GLP-1 and nail-detachment finding, the report does not name the study, its size, the medications examined or the rate of the reported outcome. It therefore does not show whether the association reflects a direct drug effect, another factor or chance. The source also gives no further detail on Carlton’s proposed Medicare use of AI, the research boot camp’s methods, or the case reports and clinical topics mentioned by the other speakers.
As an affiliate, we earn on qualifying purchases.
Follow-Up From Studies and Policy
The source material does not announce a scheduled response, policy decision or next event tied to the roundup. Further reporting would be needed to assess Kennedy’s AI comparison, including the systems and medical tasks involved and evidence from evaluations that compare their performance with clinicians. Any proposal to use AI during Medicare wellness visits would also require details on how the tool would be used and what safeguards or oversight would apply.
For the other topics, the next useful developments would be the underlying GLP-1 study and research on its findings, along with fuller clinical and research details for the tick, lymphoma and eye-health items. Until those sources are examined, the roundup’s comments are best read as attributed remarks and brief summaries, not as a substitute for the evidence or full reporting behind them.
As an affiliate, we earn on qualifying purchases.
Key Questions
What did MedPage Today publish?
It published a weekly collection of comments heard by its reporters, covering AI, GLP-1 medications, tick exposure, cancer care and eye conditions. The item was dated October 4, 2026.
Did the report prove AI gives better medical advice than doctors?
No. It quoted Robert F. Kennedy Jr. making that comparison but included no study or other evidence establishing that AI provides better second opinions than physicians.
What did the roundup say about GLP-1 medications?
It summarized research reporting that users of GLP-1 medications had a higher likelihood of onycholysis, or nail detachment, and quoted researcher Bianca Maria Piraccini. The brief item does not establish that the medications caused the condition.
What other subjects did the comments cover?
They included AI for Medicare preventive care, an AI research-writing program, lone star tick larvae, lymphoma treatment in older or frail patients, severe myopia and an unusual eye condition following a strep infection.
Source: rss
